03:49:00 EDT Sat 20 Apr 2024
Enter Symbol
or Name
USA
CA



News for U:CELZ from 2023-04-20 to 2024-04-19 - 16 items News ReleasesIn The NewsOther CAUS
DateSymPriceTypeHeadline
2024-03-27 09:00U:CELZNews ReleaseCreative Medical Technology Holdings Provides Corporate Update
2024-03-07 09:15U:CELZNews ReleaseCreative Medical Technology Holdings Inc. Announces FDA Authorization for Groundbreaking Type 1 Diabetes Prevention Therapy Under Expanded Access
2024-03-06 07:00U:CELZNews ReleaseCreative Medical Technology Holdings, Inc. Receives FDA Orphan Drug Designation for CELZ-101 in Key Transplantation Therapy
2023-12-20 09:36U:CELZNews ReleaseCreative Medical Technology Holdings (NASDAQ:CELZ) Granted FDA Clearance To Begin Phase 1/2 Clinical Trial Of AlloStem(TM) For Addressing Chronic Lower Back Pain
2023-11-15 08:00U:CELZNews ReleaseCreative Medical Technology Holdings Provides Corporate Update
2023-10-10 08:00U:CELZNews ReleaseCreative Medical Technology Holdings Announces IRB Approval for FDA Cleared Phase 1/2 Clinical Trial of StemSpine ‚ ® using AlloStem ¢ „ ¢ ("CELZ-201-DDT") Novel Cell Therapy to Treat Chronic Lower Back Pain
2023-09-19 08:00U:CELZNews ReleaseCreative Medical Technology Holdings Receives FDA Clearance to Initiate a Phase 1/2 Clinical Trial of StemSpine ‚ ® using AlloStem ¢ „ ¢ (CELZ-201-DDT) for the Treatment of Chronic Lower Back Pain
2023-08-24 10:50U:CELZNews ReleaseWhat Is Allogeneic Cell Therapy, And What ¢ € ™s Driving This Market ¢ € ™s 25%+ Annual Global Growth?
2023-07-13 09:02U:CELZNews ReleaseCreative Medical Technology Reports Advancements In Regenerative Medicine And Improvements In Financial Position In Corporate Update
2023-06-28 08:00U:CELZNews ReleaseCreative Medical Technology Holdings Regains Compliance With Nasdaq Listing Requirements
2023-06-12 08:01U:CELZNews ReleaseCreative Medical Technology Announces $2 Million Share Repurchase Program
2023-06-12 08:00U:CELZNews ReleaseCreative Medical Technology Holdings Provides Corporate Update
2023-06-09 12:30U:CELZNews ReleaseCreative Medical Technology Holdings Announces Reverse Stock Split
2023-05-31 08:00U:CELZNews ReleaseCreative Medical Technology Holdings Announces Successful Completion of the First Phase of its Program with Greenstone Biosciences, Inc. to Develop Next Generation iPSC Pipeline for ImmCelz ‚ ® Immunotherapy Platform
2023-05-22 08:30U:CELZNews ReleaseCreative Medical Technology Holdings Announces Next Milestone Achievements in ImmCelz ‚ ® Platform Development
2023-05-18 08:00U:CELZNews ReleaseCreative Medical Technology Holdings Announces Positive Top-Line Study Results for Chronic Lower Back Pain Utilizing its StemSpine ‚ ® Procedure Using AlloStem ¢ „ ¢ Allogenic Cell Line